SLC1A4: A Powerful Prognostic Marker and Promising Therapeutic Target for HCC
SLC1A4, a Na-dependent neutral amino acid transporter, was considered to participate in the various pathobiological process, including tumorigenesis. However, the correlation between SLC1A4 and Hepatocellular Carcinoma (HCC) remains unclear. In our study, integrative bioinformatics and functional pr...
Main Authors: | Xiaozhen Peng, Ruochan Chen, Shenglan Cai, Shanshan Lu, Yiya Zhang |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2021-03-01
|
Series: | Frontiers in Oncology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fonc.2021.650355/full |
Similar Items
-
Integrative Transcriptomic, Proteomic and Functional Analysis Reveals ATP1B3 as a Diagnostic and Potential Therapeutic Target in Hepatocellular Carcinoma
by: Shanshan Lu, et al.
Published: (2021-04-01) -
Identification and Validation of an Immune-Related eRNA Prognostic Signature for Hepatocellular Carcinoma
by: Shenglan Cai, et al.
Published: (2021-06-01) -
Gene Signatures and Prognostic Values of m6A Genes in Nasopharyngeal Carcinoma
by: Shanshan Lu, et al.
Published: (2020-06-01) -
Identification of Prognostic Biomarkers and Correlation With Immune Infiltrates in Hepatocellular Carcinoma Based on a Competing Endogenous RNA Network
by: Zhangya Pu, et al.
Published: (2021-05-01) -
SLC39A1 contribute to malignant progression and have clinical prognostic impact in gliomas
by: Peng Wang, et al.
Published: (2020-11-01)